
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical needs. Our vision is to leverage our proprietary G-MABTM library in conjunction with a proprietary targeted delivery modalities to generate the next generation of therapeutics for treating cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. These modalities include proprietary chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-TTM), antibody-drug conjugates (ADCs), oncolytic virus (SeprehvecTM), lymphatic drug targeting (SOFUSA), as well as bispecific antibody approaches. We are additionally developing pain management solutions, including our clinical candidates...
Biopharma,cancer,covid-19,diagnostics,infectious diseases,and non-opioid pain management
Sorrento therapeutics, inc operates in the Biotechnology research industry.
Sorrento therapeutics, inc's revenue is 11m - 100m
Sorrento therapeutics, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.